Novo Nordisk A Price to Earnings Ratio (PE) Ratios, (NVO) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Novo Nordisk A  (NYSE: NVO)
 





NVO Price to Earnings Ratio Current (Dec 31 2023) (Dec 31 2022)
Diluted EPS 12 Trailing Months IV. Quarter IV. Quarter
PE (TTM) Ratio current            1.68            36.63            33.89            33.89            33.89
Diluted EPS TTM Y / Y Change 738.15 % 56.07 % - % - % - %
Diluted EPS Y / Y Change - % 73.17 % - % - % - %
Stock performance to date -67.88 % 12.69 % 31.97 %

Price to earnings ratio Comment
Novo Nordisk A's current Price to earnings ratio has decreased due to shareprice contraction of -67.88 %, from beginning of IV. Quarter and despite eps increase of 0 %, to Pe of 1.68, from average Price to earnings ratio in IV. Quarter of 36.63.

Within Healthcare sector 38 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Novo Nordisk A Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #22
Sector #39
S&P 500 #149





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.